These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
94 related articles for article (PubMed ID: 29059648)
1. Determine the effectiveness of lipid-lowering therapy in patients with chronic obstructive pulmonary disease combined with coronary heart disease. Zhdan V; Khaymenova G; Shilkina L; Martynyuk D; Babanina M; Mamontova T Wiad Lek; 2017; 70(2 pt 2):303-305. PubMed ID: 29059648 [TBL] [Abstract][Full Text] [Related]
2. Life quality parameters in patients with combination of stable ischemic heart disease and chronic obstructive pulmonary disease. Rasputina LV; Didenko DV; Ovcharuk MV Wiad Lek; 2018; 71(8):1560-1565. PubMed ID: 30684341 [TBL] [Abstract][Full Text] [Related]
3. A prospective, randomized study: Evaluation of the effect of rosuvastatin in patients with chronic obstructive pulmonary disease and pulmonary hypertension. Chogtu B; Kuriachan S; Magazine R; Shetty KR; Kamath A; George MM; Tripathy A; Kumar DM Indian J Pharmacol; 2016; 48(5):503-508. PubMed ID: 27721534 [TBL] [Abstract][Full Text] [Related]
4. Intensifying approach to the therapy of patients with constellation of the diseases: chronic obstructive pulmonary disease and osteoarthritis. Zhdan VN; Potyazhenko MМ; Khaymenova GS; Lyulka NN; Dubrovinskaya TV; Ivanitsky IV Wiad Lek; 2017; 70(3 pt 2):578-580. PubMed ID: 28713086 [TBL] [Abstract][Full Text] [Related]
5. [Evaluation of therapy efficiency in patients with combined course of copd and osteoarthritis]. Хайменова ГС; Шилкина ЛН; Бабанина МЮ; Волченко ГВ; Ткаченко МВ; Ждан ВН Wiad Lek; 2016; 69(2 Pt 2):214-8. PubMed ID: 27487536 [TBL] [Abstract][Full Text] [Related]
6. Prognostic effects of rosuvastatin in patients with co-existing chronic obstructive pulmonary disease and chronic heart failure: A sub-analysis of GISSI-HF trial. Rossi A; Inciardi RM; Rossi A; Temporelli PL; Lucci D; Gonzini L; Marchioli R; Nicolosi GL; Tavazzi L; Pulm Pharmacol Ther; 2017 Jun; 44():16-23. PubMed ID: 28263812 [TBL] [Abstract][Full Text] [Related]
7. Use of rosuvastatin in HIV-associated chronic obstructive pulmonary disease. Morris A; Fitzpatrick M; Bertolet M; Qin S; Kingsley L; Leo N; Kessinger C; Michael H; Mcmahon D; Weinman R; Stone S; Leader JK; Kleerup E; Huang L; Wisniewski SR AIDS; 2017 Feb; 31(4):539-544. PubMed ID: 27941393 [TBL] [Abstract][Full Text] [Related]
8. [Modern tendencies in co-morbid conditions]. Ischeykin K; Potyazhenko M; Lyulka N; Sokolyuk N; Khaymenova G Georgian Med News; 2014 Oct; (235):49-53. PubMed ID: 25416217 [TBL] [Abstract][Full Text] [Related]
9. [Clinicopathogenetic features of coronary heart disease combined with chronic obstructive pulmonary diseases and efficiency of therapy with trimetazidin]. Kolomoets NM; Baksheev VI; Uvaĭsova KU Klin Med (Mosk); 2008; 86(6):38-43. PubMed ID: 18720710 [TBL] [Abstract][Full Text] [Related]
10. [Prevalence and difficulties in chronic obstructive pulmonary disease diagnosis in patients suffering from severe peripheral arterial disease]. Sleszycka J; Woźniak K; Banaszek M; Wiechno W; Domagała-Kulawik J Pol Merkur Lekarski; 2009 Aug; 27(158):92-6. PubMed ID: 19856871 [TBL] [Abstract][Full Text] [Related]
11. The Effect of Pulmonary Rehabilitation in Mountain Environment on Exercise Capacity and Quality of Life in Patients with Chronic Obstructive Pulmonary Disease (COPD) and Chronic Bronchitis. Kubincová A; Takáč P; Kendrová L; Joppa P; Mikuľáková W Med Sci Monit; 2018 Sep; 24():6375-6386. PubMed ID: 30206201 [TBL] [Abstract][Full Text] [Related]
12. The relationship between exercise capacity and different functional markers in pulmonary rehabilitation for COPD. Kerti M; Balogh Z; Kelemen K; Varga JT Int J Chron Obstruct Pulmon Dis; 2018; 13():717-724. PubMed ID: 29535512 [TBL] [Abstract][Full Text] [Related]
13. Individual approach to the treatment of obese copd patients can reduce anthropometric indicators, the level of systemic inflammation and improve the quality of life. Savchenko LV; Kaidashev IP Wiad Lek; 2018; 71(3 pt 1):451-459. PubMed ID: 29783205 [TBL] [Abstract][Full Text] [Related]
14. [The importance of the at risk COPD patients (Stage 0) and clinical differences]. Kömüs N; Tertemiz KC; Sevinç C Tuberk Toraks; 2008; 56(4):382-9. PubMed ID: 19123073 [TBL] [Abstract][Full Text] [Related]